Exact Sciences Corporation (EXAS) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Exact Sciences Corporation  (NASDAQ: EXAS)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Exact Sciences's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Exact Sciences's ROI in the fourth quarter of 2025?
Exact Sciences Corporation recorded a cumulative net loss of $-208 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -3.96%.

Within the Healthcare sector 276 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 1154 to 3098.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM -8.28 % -11.51 % -8.21 % -4.57 % -3.53 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 5,219 5,316 5,275 5,209 5,196
Return On Investment (TTM) -3.96 % -18.8 % -18.53 % -18.18 % -17.96 %
EXAS's Overall Ranking # 3098 # 1154 # 2674 # 876 # 1251
Seq. Investment Change TTM 0.11 % -3.27 % -3.25 % -2.11 % -3.42 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -208 -987 -1,005 -1,020 -1,029

EXAS Company Profile >> Back to EXAS Roi Comparisons >> See Annual EXAS Return On Investment



Return On Investment EXAS's Ranking
Within: No.
Industry # 17
Sector # 277
Overall # 3098

Return On Investment Statistics
High Average Low
-2.97 %
-22.7 %
-55.29 %
(Jun 30 2024)   (Jun 30 2016)







Financial Statements
Exact Sciences's IV. Quarter Investments $ 5,219 Millions EXAS's Balance sheet
Exact Sciences's IV. Quarter Income $ -86 Millions Quarterly EXAS's Income Statement
EXAS's Income by Division See EXAS's Income by Division


EXAS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 5,219 5,196 5,957 5,814 4,349
Y / Y Investment Growth 0.45 % -12.77 % 2.45 % 33.68 % 33.03 %
Net Income in Millions -208 -1,029 -204 -624 -849
Y / Y Net Income Growth - - - - -
Annual Return On Investment -3.98 % -19.8 % -3.43 % -10.72 % -19.51 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EXAS's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EXAS's Competitors
Subscribers only: Roi for Exact Sciences's Suppliers
Subscribers only: Return On Investment for EXAS's Customers

Other Ratios
EXAS's Roa EXAS's Inventory Turnover Ratio EXAS's Growth Rates EXAS's Dividend Statistics
EXAS's Profitability Ratios EXAS's Asset Turnover Ratio EXAS's Dividend Growth
EXAS's Roe EXAS's Valuation Ratios EXAS's Financial Strength Ratios EXAS's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-06-22T16:30:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.